Rumors swirled in the British press for nearly a decade that Allen hooked up with Oasis frontman Liam Gallagher on an ...

VATICAN CITY (AP) — King Charles III and Queen Camilla prayed Thursday with Pope Leo XIV in an historic visit to the Vatican ...

Eli Lilly: Was I Too Cautious? We don't get everything right, do we? While I nailed the upgrade in Eli Lilly and Company (NYSE:LLY) stock in my last write-up in August, some of you might contend that ...

Palantir is one of the hottest companies in the red-hot artificial intelligence sector. The stock has been on an unbelievable run. Companies may use stock splits after a stock has experienced strong ...

The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, to ...

UnitedHealth's Optum Rx makes money on the "spread" — the difference between the list price and the net price after rebates. But what happens if TrumpRx and MFN pricing collapse that spread? Fewer ...

Eli Lilly stock (NYSE: LLY) should be on your radar. Here’s why – it is presently trading within the support range ($688 – $761), price points from which it has previously bounced significantly. Over ...

President Donald Trump announced on Sept. 25 that the U.S. will impose a 100% tariff on branded or patented pharmaceutical products that enter the country starting Oct 1. But Eli Lilly, one of ...

Eli Lilly’s planned $5-billion biomanufacturing facility in Goochland County, Va., about 20 miles west of downtown Richmond, represents one of the largest private capital investments in state history.

Corey Dambacher was working in Oregon when he discovered a type of ribonucleic acid capable of creating unique types of proteins that express themselves on the surfaces of cancer cells. It’s just the ...

While Eli Lilly is rethinking its biotech incubator plans in Europe, the Big Pharma has gone ahead and opened its San Diego site. The Gateway Labs are co-working spaces for researchers that also act ...

Eli Lilly (LLY) remains a strong growth company, driven by leadership in the booming GLP-1 and diabetes drug markets despite recent share price weakness. LLY's aggressive investments in manufacturing, ...